Joshua Apte PhD

• Assistant Professor
• Environmental Health Sciences

https://publichealth.berkeley.edu/people/joshua-apte/

Finally medications zolpidem generic compazine 5 mg with mastercard, prolactinomas are a major cause of prolactin elevation; occasionally treatment wetlands purchase compazine 5 mg overnight delivery, adenomas cosecrete prolactin with other anterior pituitary hormones withdrawal symptoms 5 mg compazine purchase otc. Diagnosis A patient who presents with symptoms of hyperprolactinemia can be evaluated with a random measurement of serum prolactin treatment models buy 5 mg compazine otc. If the prolactin level is mildly elevated the measurement should be repeated medications voltaren purchase compazine with a mastercard, given the various physiologic factors (listed earlier) that can transiently elevate prolactin. If the level remains high, further evaluation should include a detailed history of recent medication use, a pregnancy test (if the patient is female), and thyroid and renal function tests. Pituitary adenomas are classiied as a microadenoma if they are <10 mm in size and as macroadenomas if they 10 mm in size. In general, in the case of prolactinomas, the magnitude of prolactin elevation correlates well with radiographic estimates of tumor size. In such cases, treatment with dopamine agonists will lower prolactin levels but will not cause a decrease in tumor size (see later). Patients with macroadenomas extending beyond the sella turcica should undergo visual ield testing and evaluation of anterior pituitary function. Women can also safely be treated with oral contra ceptives or estrogen/progesterone replacement to prevent bone loss. Both medications efectively lower serum prolactin levels, restore gonadal function, and reduce tumor size. Cabergoline is the preferred choice because it is more eicacious than bromocriptine, is usually better tolerated, and can be administered once or twice weekly rather than daily. Both bromocriptine and cabergoline are usually started at low doses and titrated until prolactin levels normalize. In women attempting to conceive, the medication is typically discontinued when pregnancy is achieved. After 2 years of therapy, if prolactin levels have normalized and there has been signiicant tumor volume reduction on imaging, it is reasonable to taper and discontinue dopamine agonist therapy while monitoring prolactin levels. It is worth noting that the ergot-derived dopamine agonists, pergolide and cabergoline, have been associated with increased risk of cardiac valve regurgitation in patients treated with these medications for Parkinson disease. However, the doses used for the treatment of Parkinson disease are much higher than those used for hyperprolactinemia, and there is no evidence that valvulopathy occurs at the lower cumulative doses used for this indication. In addition to dopamine agonists, treatment options for prolactinomas include surgery and external radiation. Transsphenoidal removal of a prolactinoma is indicated when a macroadenoma does not respond to medical therapy or when there is tumor growth despite medical treatment. If a substantial amount of tumor remains after surgical excision, external radiation may occasionally be necessary. Accelerated growth and gigantism occur only if the disease develops in adolescence before epiphyseal plates are closed. In adults, the most common clinical features are coarsen ing of facial features, such as frontal bone bossing and jaw prognathism, and softtissue swelling that can lead to increases in ring, shoe, or hat size. Patients also frequently complain of increased sweating, and premenopausal women may note menstrual irregularities. Cardiac abnormalities such as arrhythmias, hypertension, valvular disease, and heart failure, as well sleep apnea secondary to airway soft tissue swelling, may develop (Box 47. In addition, acromegaly is associated with an increased risk of certain tumors, such as colonic polyps. More than 75% of patients with acromegaly have a macroadenoma at diagnosis, and if that is the case they may additionally present with symptoms of mass efect, such as headaches, visual ield defects, and pituitary hormone deiciencies. Diagnosis Adults Coarsening of facial features (frontal bone bossing; jaw prognathism) Soft tissue swelling (acral enlargement: increased ring, shoe, hat size) Arthralgias Osteoarthritis Excessive sweating Menstrual irregularities Hyperglycemia Hyperlipidemia Cardiac abnormalities (hypertension, heart failure, arrhythmias, valvular disease) Sleep apnea In addition, given the signiicant number of patients who present with macroadenomas, these patients should undergo evaluation of other pituitary hormones to rule out hypopituitarism. Because many adenomas cosecrete growth hor mone and prolactin, the latter should also be measured. During treatment for acromegaly, it is important to continue monitoring for associated morbidities including pituitary insuiciency, cardiovascular dysfunction, sleep apnea, hyperglycemia, musculoskeletal diseases, and colonic polyps. Transsphenoidal surgery is the treatment of choice for acromegaly in most patients. Certain tumor characteristics such as size, presence of extrasellar growth, and dural invasion are associated with lower rates of cure. When surgery fails to normalize the biochemical parameters, or when patients refuse or have a contraindication to surgery, medical therapy should be initiated. Somatotroph adenomas express dopamine receptors, and dopamine agonists, particularly cabergoline, have been used in the management of acromegaly, but they are not as efective as other agents. Radiation therapy is generally reserved as a last resort for patients who have undergone surgery and subsequently were resistant to or intolerant of medical treatment. Radiotherapy slows tumor growth and can efectively normalize biochemical parameters, but its efects are delayed, and hypopituitarism is a common adverse efect. Clinical features of Cushing syndrome include fatigue, weight gain, hirsutism, proximal muscle weakness, hypertension, hyperglycemia, and hypokalemia, as well as loss of bone mineral density. Patients with Cushing syndrome have a characteristic physical appearance with facial plethora, moon-shaped facies, and supraclavicular and dorsocervical fat pads, and they may have wide purple striae or ecchymoses. If the result of one of these tests is abnormal, it should be conirmed by performing another test. If values are elevated on both tests, further evaluation is required to determine the etiology of the disease. If sampling results are consistent with Cushing disease, transsphenoidal surgery is the treatment of choice. Medications that inhibit adrenal steroidogenesis (and the diagnosis and management of Cushing syndrome) are reviewed in Chapter 50 on adrenal gland disorders. A selective glucocorticoid receptor antagonist, mifepristone, is approved for the treatment of hyperglycemia in Cushing syndrome in those who have failed surgery or who are not surgical candidates. In cases of residual tumor or contraindications to surgery, somatostatin analogues are an alternative therapeutic option. Genetic Syndromes Associated With Pituitary Tumors Some genetic syndromes are associated with the formation of pituitary tumors. Tumors of gonadotropic origin may also secrete gonadotropin subunits or proteins without functional activity. In fact, many adenomas considered nonfunctional are actually gonadotropic in origin. When they become suiciently large, similar to all other pituitary tumors, gonadotroph adenomas can cause mass efects. Mass lesions in or near the hypothalamus or pituitary gland can cause partial or complete hypopituitarism. By far the most common such lesions are pituitary adenomas, which may be functioning or nonfunctioning. Excision or shrinkage of the tumor may result in restoration of pituitary function, although if pituitary tissue has been destroyed, this is unlikely, and lifelong hormone replacement therapy will be required. In addition to benign tumors afecting the pituitary gland, many types of cancer, most commonly breast and lung, can metastasize to the hypothalamus or the pituitary and cause hypopituitarism. Iatrogenic causes of pituitary deiciency may ensue after pituitary surgery or after radiation therapy. Postoperative patients should undergo biochemical evaluation to detect changes in pituitary function. Patients who undergo pituitary radiation, either for functioning adenomas after incomplete resections or for brain tumors, should be screened at regular intervals, as many will eventually develop some degree of hypopituitarism. Pituitary apoplexy is the infarction of or hemorrhage into the pituitary gland, causing abrupt damage to the tissue. Sheehan syndrome, which is pituitary necrosis after postpartum hemorrhage, is characterized by hypopituitarism and inability to breastfeed and can present immediately or several years after childbirth. Less common causes of hypopituitarism include empty sella syndrome, which results from either a congenital or an acquired sellar diaphragmatic defect through which arachnoid herniates and enlarges the pituitary fossa. Destruction of the Pituitary Stalk Trauma Compression by masses Surgical damage Hypothalamic Causes Trauma Masses Craniopharyngioma Meningioma Other tumors Tumor metastases Radiation Functional Starvation/anorexia nervosa Stress/critical illness Most patients with a congenital empty sella have normal pituitary function; approximately 15% have mild hyperprolactinemia. Traumatic brain injuries can lead to hypothalamic or pituitary damage either immediately or years afterward, and patients should be monitored for hypopituitarism. Granulomatous diseases, including sarcoidosis, giant cell granuloma, eosinophilic granuloma, and Wegener granulomatosis can afect the hypothalamus or pituitary and thus lead to hypopituitarism. Lymphocytic hypophysitis, a difuse iniltration of the anterior pituitary, occurs predominantly in women and is often irst evident during pregnancy or after delivery. Recently, hypophysitis has been identiied to occur as the result of treatment with ipilimumab, an immune checkpoint inhibitor used to treat malignant melanoma and other cancers. Note compression of nearby struc- because there are substantial overlaps between normal and deicient ranges. Instead, in most cases, serum levels of the hormones made by target organs (in response to stimulation from the pituitary) are used to assess the status of pituitary function. If the concentrations of target organ hormones are equivocal, subsequent stimulation tests can be performed to determine pituitary function. After the clinical and biochemical diagnosis of hypopi tuitarism has been established, a radiographic study is indi cated to determine whether a mass or other abnormality is present. Patients with panhypopituitarism on standard replace ment therapies have increased prevalence of obesity as well as osteopenia and fractures. In addition, for reasons that remain poorly understood, cardiovascu lar mortality is increased in these patients. Deiciency of each pituitary hormone has a unique presentation, diagnostic strategy, and management, and these are addressed subsequently. In addition, several types of infections, such as meningitis or an abscess, can involve the hypothalamus or pituitary and cause pituitary insuiciency. Finally, there can be functional hypopituitarism: reversible suppression of hypothalamic function from severe stress such as starvation or critical illness. If left untreated, particularly in the context of physiologic stressors such as illness, secondary adrenal insuiciency can lead to vascular collapse and death. On physical examination, orthostatic hypotension may be present and should be assessed. Cortisol deiciency leads to inadequate vascular tone, increased vasopressin, and water retention, and hyponatremia may ensue. In addition, in secondary adrenal insuiciency, adrenal aldosterone production is preserved, so serum potassium concentration should be normal; in primary disease, aldosterone deiciency may result in both hyponatremia and hyperkalemia. Depending on the etiology of the hypopituitarism, patients may additionally present with symptoms of mass efects including headaches and visual ield deicits or other neurologic abnormalities. Pituitary adenomas and other tumors that afect this region are typically slow growing, so endocrine deiciencies and mass efects tend to develop slowly. However, when symptoms are acute in onset or abruptly exacerbated, an event such as pituitary apoplexy associated with rapid expansion in size and infarction of the gland should be considered. An increase in the serum cortisol concentra tion to 18 to 20 g/dL or more is considered a normal response. In patients with severe corticotropin deiciency the adrenal glands atrophy, and therefore the serum cortisol response to stimulation will be diminished (abnormal). Of note, this test is not useful in the acute setting: test results will be normal before adrenal atrophy has occurred, and this can take weeks to months to develop. Although this test is considered the gold standard for diagnosis of secondary adrenal insuficiency, relected by an insuicient rise in serum cortisol, it is rarely conducted because of the safety concerns of inducing hypoglycemia. When the diagnosis of adrenal insuiciency is made, or when clinical suspicion is high, glucocorticoid therapy should be initiated immediately. Patients can be treated with hydrocortisone 15 to 30 mg daily, administered in divided doses in the morning and afternoon. Overtreatment should be avoided to decrease risks of iatrogenic hypercortisolism such as bone loss. Patients should be instructed to double or triple their steroid doses for periods of stress such as febrile illnesses. Mineralocorticoid replacement is not necessary in patients with secondary adrenal insuiciency, as aldosterone production is intact. In patients with multiple pituitary hormone deiciencies, it is important to treat adrenal insuiciency before starting thyroid hormone replacement. Laboratory studies should be repeated 4 to 6 weeks after initiation of therapy to evaluate appropriateness of dose. Gonadotropin deiciency before puberty results in failure to progress through sexual maturation. In adult premenopausal women, estrogen deiciency manifests as infertility, anovulatory cycles, and oligomenorrhea or amenorrhea. Because estrogen levels are low at baseline in postmenopausal women, if they develop hypopituitarism they usually present with symptoms of other hormonal deiciencies or of mass efects. Long-standing testosterone deiciency results in sparse facial and body hair and testicular atrophy. Gonadotropin deiciency can occur secondary to all of the causes of hypopituitarism listed in Box 47. Physiologic stress can also cause acquired derangements in the hypothalamic-pituitarygonadal axis. In premenopausal women, the best assessment of gonadotropin status is the menstrual history; regular menses indicate at least some gonadotroph function, and measurement of gonadotropins or estradiol provides little additional information. In these patients, gonadotropin levels are normally high, so low or normal levels are inappropriate and conirm gonadotropin deiciency and anterior pituitary dysfunction. A serum testosterone concentration should always be measured as part of the diagnostic workup (see Table 47. Treatment for hypogonadism consists of gonadal steroid replacement unless fertility is desired. In women of reproductive age, estrogen and progesterone therapy are recommended to restore the normal hormonal milieu and prevent bone loss.

Syndromes

• Sexual problems such as low libido
• Feelings of guilt and shame about sex
• Pulmonary hypertension
• Be adapted to the specific age and capabilities of the child. Programs for 4 year olds are different from those developed for children 8 or 12 years of age in terms of degree of responsibility of the child and parents.
• White blood cell count in a sample of peritoneal fluid
• Bleeding
• Cold and dry air in the winter
• Protein - urine

Patients and families should be educated about the signs and symptoms of cord compression to allow early detection treatment 3rd degree av block order compazine cheap online. A recent study from 2010 suggests that this education may allow for an earlier diagnosis of cord compression with 62% of patients being ambulatory at the time of diagnosis administering medications 7th edition order compazine 5 mg otc. Signs of cord compression on physical examination include numbness medications on backorder best order for compazine, weakness in the extremities medicine review buy compazine on line amex, or loss of bladder or bowel function symptoms vertigo order genuine compazine line. In patients with a known diagnosis of cancer, treatment should be initiated immediately. For patients without a diagnosis, a biopsy should be performed while initiating therapy. Most commonly, treatment of cord compression includes the administration of steroids in addition to radiation therapy. Prompt therapy is critical because outcome for patients who are ambulatory at the time of diagnosis is good. Unfortunately, for patients who have already developed paralysis at the time of diagnosis, only 10% of these patients will resume ambulation. Early studies did not demonstrate a beneit of decompressive laminectomy compared with radiation therapy alone. A more recent matched pair analysis performed in 2010 looked at the outcome of 108 patients receiving surgery in addition to radiation therapy compared with 216 patients receiving radiation therapy alone. Given the signiicant complications of the surgery, careful selection of patients with a good performance status and adequate life expectancy is needed. For patients with recurrent spinal cord compression, surgery and chemotherapy may be considered. Chemotherapy is often only useful in patients with tumors that respond well to chemotherapy. Brain Metastasis Central nervous system involvement by cancer can be found in 25% of patients. Cancers that most commonly metastasize to the brain are lung cancer, breast cancer, renal cell cancer, and melanoma. Presenting signs of central nervous system involvement include headache, nausea, vomiting, new onset seizures, and focal neurologic deicits. Abrupt presentations resembling a stroke may occur in the setting of hemorrhage associated with metastasis. Edema resulting from metastatic lesion results in increased intracranial pressure. A biopsy should be obtained especially if this represents the only site of disease. In patients with multiple brain metastases, whole brain radiation therapy should be initiated. For patients with a single brain metastasis and controlled systemic disease, surgical excision followed by radiation therapy may be considered for younger individuals. Tumors that are not responsive to radiation therapy should also be considered for resection. Stereotactic radiosurgery may be used in treating tumors that have recurred or are in an anatomically sensitive location. Malignant pericardial disease is common and may be present at autopsy in up to 10% of patients with cancer. Patients with symptomatic pericardial disease or tamponade may present with complaints of dyspnea, cough, or orthopnea. Other signs include sinus tachycardia, jugular venous distention, hepatomegaly, and peripheral edema. Placement of a pericardial window and, in some cases, pericardial stripping may be required. Acute pericardial tamponade with hemodynamic instability is a medical emergency and requires immediate drainage. Intestinal or Urinary Tract Obstruction Intestinal obstruction may be a complication associated with advanced cancers particularly colorectal, gastric, and ovarian carcinoma. Other cancers such as melanoma, breast cancer, and lung cancer that have metastasized to the abdomen can also be associated with obstruction. Symptoms of obstruction typically include pain, which is colicky in nature, or abdominal distention. Urinary tract obstruction occurs most commonly in patients with either prostate, bladder, or gynecologic cancers. Other etiologies include extrinsic compression from lymphoma and sarcoma in the retroperitoneum. Less commonly, radiation therapy to the pelvis or retroperitoneum may result in ibrosis leading to obstruction. In cases of bladder outlet obstruction, a suprapubic cystostomy tube may be needed for urinary drainage. Prolonged and severe hyperphosphatemia may result in a marked decrease of the serum calcium concentration, but symptomatic hypocalcemia rarely develops. Hyperuricemia Xanthine oxidase catalyzes the breakdown of hypoxanthine and xanthine to uric acid. However, within the acidic environment of the renal tubules, uric acid may be present in the nonionized less soluble form. Renal insuiciency may develop because of the development of uric acid crystals in the renal tubules as well as the distal renal collecting system. Nephrolithiasis caused by the development of uric acid stones is uncommon and usually develops only in patients with chronic hyperuricemia. Allopurinol is the standard treatment for both the prevention and treatment of hyperuricemia. Allopurinol is usually administered orally at a dose of between 200 and 300 mg/m2/d with typical doses of 300 to 600 mg/d with a maximum oral dose of 800 mg/d. Allopurinol is cleared renally, and the dose should be adjusted in older patients or patients with chronic renal failure. Both azathioprine and 6-mercaptopurine are metabolized by xanthine oxidase; therefore use of these agents should be avoided. Rasburicase is a recombinant urate oxidase enzyme that catalyzes the enzymatic oxidation of uric acid into its inactive, water-soluble metabolite, allantoin. Data from preclinical studies suggested that rasburicase remains active ex vivo, leading to spuriously low uric acid levels in the absence of specialized handling: sample collection in prechilled heparin tubes, transportation to the laboratory and centrifugation at 4°C, and testing within 30 minutes. However, an independent study of these requirements in treated patient samples has not been well established. Rapid and early consultation of the nephrology team should be initiated if the renal function starts to deteriorate or in the case of severe hypervolemia that is not responsive to loop diuretics. Hyperkalemia Hyperkalemia is the most important, life-threatening electrolyte abnormality that develops during tumor lysis syndrome. Hyperkalemia results from the release of large intracellular stores caused by cell lysis. Pseudohyperkalemia may result from poor phlebotomy technique, hemolysis, or because of marked leukocytosis or thrombocytosis. Measuring the plasma potassium using a heparinized tube may be required in the setting of a markedly elevated platelet count. Hyperkalemia leads to the partial depolarization of the resting cell membrane potential, and prolonged depolarization will eventually lead to impaired excitability resulting in muscular weakness, which may progress to laccid paralysis. Unfortunately, cardiac toxicity does not correlate with the degree of hyperkalemia. Furthermore, medications that interfere with potassium metabolism such as nonsteroidal antiinlammatory drugs and angiotensin-converting enzyme inhibitors should be discontinued. Oral cation-exchange resins promote the exchange of potassium and sodium ions within the lumen of the gastrointestinal tract. A dose of 15 to 30 g of sodium polystyrene sulfonate will generally lower the serum potassium concentration by 0. Alkalization of the serum with bicarbonate will also lead to a shift of potassium into cells. Hemodialysis and continuous venous-venous hemoiltration are the most efective methods for efectively lowering the serum potassium levels especially in patients with either preexisting or acute renal failure. Peritoneal dialysis is not as efective as hemodialysis in lowering the serum potassium level, and its initiation should be avoided in patients receiving chemotherapy. Hyperphosphatemia Hyperphosphatemia results from the release of intracellular phosphate stores into the serum as a result of cell lysis and is deined as a serum phosphate level above 1. Spurious hyperphosphatemia may be seen in patients with a marked paraprotein level. Hyperphosphatemia is a potentially dangerous condition caused by extraosseous calciication. Although it should only serve as a guideline, a calcium-phosphorus product (serum Ca [mg/dL] × serum P [mg/dL]) >70 suggests a potential risk of metastatic calciication. Aluminum-based antacids bind to phosphorus in the gut and prevent further absorption. Although the chronic use of these agents may lead to aluminum toxicity, they are safe and efective for short-term use. Calcium acetate is dispensed as two tablets or gel caps (667 mg) with each meal, and the dose can be increased as long as hypercalcemia does not develop. Sevelamer, a cross-linked polyallylamine hydrochloride, is a cationic polymer that binds intestinal phosphate. Over alkalization of the serum will increase the binding of calcium to proteins and result in a further reduction of the serum calcium level. Transient hypocalcemia may also arise from repeated transfusions of blood products because of the use of citrate as an anticoagulant. Transient hypocalcemia is seldom clinically signiicant, but, if longstanding, it can lead to several serious clinical manifestations. Rarely, patients may become irritable, depressed, or psychotic as a result of severe prolonged hypocalcemia. Calcium supplementation with oral calcium or calcium gluconate in severe symptomatic cases must be taken with caution, especially if the calcium-phosphate product is >70. In general, calcium should not be given in asymptomatic patients as this may precipitate calcium phosphate deposition. Hypercalcemia Hypercalcemia is the single most common metabolic disorder in patients with cancer. Hypercalcemia caused by an underlying malignancy must be diferentiated from hypercalcemia because of primary hyperparathyroidism. Serum calcium is highly bound to albumin; therefore the total serum concentration will vary depending on serum protein concentrations. Measurement of the ionized calcium level can often assist in sorting out diicult cases. An adjustment for the total serum calcium concentration based on the serum albumin concentration can be made as follows: Corrected calcium = serum calcium + 0. Clinical symptoms that arise from hypercalcemia are as a direct result of both the rate of rise and the absolute serum calcium level (Table 17. With continued rise, patients may begin to experience neurologic symptoms such as fatigue, lethargy, muscle weakness, confusion, seizure, and even coma. Most patients with hypercalcemia present with marked dehydration caused by anorexia, nausea, and vomiting as well as polyuria caused by calciuresis. Appropriate volume expansion will not only increase renal blood low but also improve calcium excretion. Once euvolemia has been established, forced diuresis with furosemide can be initiated. Bisphosphonates absorb to the surface of hydroxyapatite and inhibit the release of calcium from bone. Pamidronate is typically infused at a dose of 60 to 90 mg over 2 to 4 hours, and zoledronic acid is administered at a dose of 4 mg in patients with normal renal function. Peak levels of both pamidronate and zoledronic acid have been associated with renal tubular dysfunction. However, infusion rates of 30 to 45 minutes are now recommended, and the dose should be reduced in patients with renal insuficiency. To determine the cause of hyponatremia, it is important to measure plasma osmolality, urine osmolality, and urine sodium concentration as well as urine potassium concentration. Plasma sodium concentrations that fall slowly over long periods of time are often well tolerated, and patients usually remain asymptomatic. As the plasma sodium concentration falls to <120 mmol/L, patients may develop neurologic symptoms, which include headache, lethargy, and confusion and, if left uncorrected, may develop into seizures and coma. In patients with mild-to-moderate hyponatremia, this can be eiciently corrected by restricting the patients free water intake. In patients with severe hyponatremia with the development of neurologic symptoms, it may be necessary to administer hypertonic saline. One must be extremely careful with the administration of hypertonic saline to avoid central pontine myelinolysis. Development of fever in a neutropenic patient is a medical emergency requiring hospitalization and prompt administration of broad-spectrum antibiotics. Gram-negative rod infections are of most concern; therefore antibiotics with anti-Pseudomonas coverage should be used. Alternatives include a semisynthetic penicillin in combination with an aminoglycoside. If a skin source or line-associated source is suspected, administration of antibiotics with gram-positive coverage, such as vancomycin, should also be considered. Patients should remain on broad-spectrum antibiotics until resolution of neutropenia. If an organism is identiied, antibiotics should be altered to assure activity against this organism, but broad-spectrum antibiotics should be continued because other pathogens not identiied may also be present. For patients with prolonged neutropenia and persistent fever, the addition of antifungal agents should be considered. Typhlitis Neutropenic enterocolitis, or typhlitis, is the necrosis of the cecum and adjacent colon.

A careful history of drug intake medicine effects order compazine without a prescription, both prescribed and over-the-counter medications symptoms 5 days post embryo transfer order compazine 5 mg on-line, may be useful in the evaluation of proteinuria medicine reminder discount compazine 5 mg online. Dysmorphic red blood cells and red cell casts are indicative of glomerular pathology medications not to mix purchase compazine 5 mg with visa. Both overlow proteinuria with Bence-Jones proteins and tubular proteinuria can be detected by the urine immune electrophoresis looking for monoclonal light chains symptoms rheumatoid arthritis order compazine 5 mg online. In amyloido sis, there will be large amounts of albumin and light chains that are monoclonal in most patients. Both solid tumors and lymphomas can present with nephrotic syndrome, especially in the elderly. An exhaustive evaluation for an underlying malignancy does not need to be undertaken for all cases of nephrotic syndrome. Kidney ultrasound will reveal congenital absence or hypoplasia of one kidney, which leads to focal sclerosis. Kidney ultrasound may reveal hydronephrosis, and a void ing cystoureterogram may reveal relux as the etiology for proteinuria, especially in children. Therapy of Specific Kidney Conditions herapeutic approaches are summarized in Table 62. Overlow proteinuria is fully evaluated, and treatment is of the underlying myeloma, leukemia, or lymphoma. Patients with tubulointerstitial disease should have treatment for the underlying disorder including withdrawal of ofending drugs. Multiple myeloma with myeloma kidney or cast nephropathy will need speciic therapy. Idiopathic nephrotic syndrome is treated with ste roids alone for minimal change disease and focal scle rosis and a combination of steroids and melphalan or cyclophosphamide for membranous nephropathy. Kidney Biopsy Kidney biopsies are usually done under real-time ultrasound guidance with a severe complication rate of about 1% to 2% of signiicant bleeding requiring transfusion. Consideration of kidney biopsy in patients with <1 g of proteinuria per day and in patients with isolated hematuria has to be individualized. Refractory cases of minimal change disease and focal sclerosis may be treated with steroids combined with mycophenolate or cyclophosphamide. Secondary causes of nephrotic syndrome are treated with more disease-speciic approaches. Diabetic nephropathy is treated with the more general treatments for proteinuric kidney disease. Systemic lupus is treated, based on the stage of disease after kidney biopsy, with steroids and adjuvant immunosuppressive therapy. Treatment for nephrotic syndrome secondary to malignancy is directed on treatment of the malignancy. Rapidly progressive glomerulonephritis is often treated empirically while a diagnostic evaluation is in progress because delay in treatment may lead to irreversible kidney dysfunction. In general, high-dose pulse steroids of methylprednisolone at doses of 500 to 1000 mg per day for 3 consecutive days with intravenous cyclophosphamide 2 mg/kg/d for 3 days are often used in severe cases. Subacute bacterial endocarditis is treated with antibiotics without immunosuppression, although in certain cases, immunosuppression may be used with caution. Cryoglobulinemia is treated with plasma exchange in the acute setting and immuno suppression with steroids and cyclophosphamide after plasma exchange. General Management of Proteinuria All patients with proteinuria are managed with some com mon approaches: 1. In some patients, an acute rise in serum creatinine may occur and a certain amount should be expected. Protein intake: Protein restriction is controversial and should be used cautiously in malnourished patients. Patients with chronic kidney disease are at increased risk for cardiovascular disease and need meticulous management of risk factors. Patients with nephrotic syndrome tend to develop hyperlipidemia, which increases the risk for cardiovascular disease. Aldosterone antagonists: Aldosterone antagonists should be considered for the control of proteinuria. Anticoagulation: Patients with nephrotic syndrome are at risk for thromboembolic complications. In patients with severe nephrotic syndrome (albumin <2 g/dL) anticoagulation may be favored. Because patients with membranous glomerulonephritis are at highest risk, this may be particularly true in these patients. Empirical anticoagulation of patients with severe membranous nephropathy is controversial. However, patients should be monitored for the development of renal vein thrombosis, deep venous thrombosis, and pulmonary emboli, all of which warrant anticoagulation until resolution of the nephrotic syndrome. Vitamin D deiciency: Patients with nephrotic syndrome and those with kidney insuiciency develop vitamin D deiciency, which should be evaluated for and treated with replacement. His urine sediment examination shows 20 to 50 erythrocytes per high-power ield, but no leukocytes or casts are present. His urinalysis showed 3+ pro tein and 3+ heme, and the sediment showed many red cells many of which were dysmorphic. A 45-year-old white male presents with massive lower extremity edema and foamy urine. His urine sediment examination shows fatty casts and an oval fat body cast but no cellular casts. A 41-year-old African-American male with a history of hypertension and long-standing substance abuse presents to your urgent care clinic with generalized edema of 3 weeks duration. He says that he noticed progressive lower extremity edema and had been seen by your colleague in urgent care the previous week and started on furosemide, 40 mg twice daily. His past medical history includes depression, hypertension for the past 1 year, and drug dependency. He is single, lives alone, and volunteers a history of longstanding intermittent cocaine abuse, heavy alcohol consumption (he says he quit 2 years ago), and tobacco consumption (1 pack per day for the past 25 years). Physical examination shows no acute distress and is remarkable for vital signs showing a temperature of 36. Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology. Tubulointerstitial nephritis presents with azotemia, pyuria, and/or white cell casts. Acute Nephritic Syndrome his is characterized by hematuria, red cell casts, azotemia, variable proteinuria, oliguria, edema, and hypertension. It is often caused by a systemic disease that requires a renal biopsy to establish its diagnosis and guide treatment. Unexplained Acute Kidney Injury Most often the diagnosis is not based on a renal biopsy. Biopsy is indicated in those settings in which the diagnosis is uncertain, as may sometimes be the case with acute interstitial nephritis secondary to drugs. Accumulating evidence suggests that systemic T-cell dysfunction results in the production of a circulating permeability factor or cytokine abnormality. In children, the most common cause of nephrotic syndrome is minimal change disease. Treatment in children consists of prednisone 60 mg/m2/d (maximum doses of 80 mg/m2/d) until a remission has been induced (or for 4 weeks, whichever is shorter) and then 35 to 40 mg/m2 every other day for about 12 weeks followed by slow tapering. Treatment is generally continued for about 8 weeks in children and 16 weeks in adults, with slow tapering thereafter. About 95% of children and about 90% of adults will respond with a complete remission of proteinuria with this initial regimen, earlier in children and later in adults. However, many patients (40%­60%) will relapse either during the tapering phase of treatment (steroid-dependent relapses) or weeks, months, or even years later. Some patients have frequent relapses (>2 year) and require repeated courses of therapy. Diabetics: measure urine microalbumin Protein electrophoresis if high suspicion for light chains B. Functional Albuminuria Changes in glomerular pressure Fever, exercise Orthostatic albuminuria Proteinuria disappears when recumbent C. Significant Albuminuria 300 mg/24 h Careful history/physical Urinalysis Renal function tests Funduscopy for diabetics Renal ultrasound <300 mg/24 h Nondiabetic Negative history/physical Repeat 24 h collection in 6 months F. Urinary protein excretion may be very high, sometimes 20 g/d, and the proteinuria is nonselective with a high fractional excretion of IgG (often >0. In 2014, a second autoantigen, thrombospondin type 1 domain-containing 7A, was identiied. At presentation, 60% to 70% of patients have the nephrotic syndrome with the remainder having subnephrotic proteinuria (<3. Microscopic hematuria is common (30%­40%), but macroscopic hematuria and red cell casts are rare. If steroids are used alone, oral prednisone in a dose of 1 mg/kg/d or 2 mg/kg every other day is given for 2 to 3 months with slow tapering over another 2 to 3 months. However, only about one-half of the patients respond to steroid therapy, and patients frequently need adjunctive therapy, such as cyclosporine (4­5 mg/kg/d for 3­6 months). Unfortunately, evidence is largely based on observational data, and treatment is expensive (Madan et al. In patients with severe nephrotic syndrome, clinical manifestations of hypercoagulability may arise (deep venous thrombosis, pulmonary embolism, or renal vein thrombosis). Treatment with glucocorticoids alone is insuicient therapy for membranous glomerulopathy. Recommended treatment is with a combination of steroids and alkylating agents such as cyclophosphamide or chlorambucil. One hundred percent of patients achieved partial remission and 93% of patients achieved complete remission at a median time of 2 and 13 months. Patients with nephrotic-range proteinuria, over 6 g for over 6 months, tend to pursue a progressive course. Young women with moderate proteinuria tend to do very well; older males fare less well. Spontaneous complete or partial remissions of proteinuria occur in about 40% of patients, usually within 3 to 5 years of diagnosis. Among those who undergo remission either spontaneously or with drugs, about 67% remain in remission, whereas the rest either have recurrent relapses without progression to renal failure (20%) or progress to renal insuiciency (13%). Nephritic Syndrome Glomerulonephritis is deined as acute inlammation of the glomerular compartment. Nephritis results from injury to one or more of the cell types or structures that comprise the glomerulus; endothelial, epithelial, or mesangial cells; or the basement membrane. Injury can be categorized into several diferent pathologic patterns, which are broadly grouped into nonproliferative or proliferative types. Serologic testing for autoantibodies and evaluation of the pattern of hypocomplementemia are usually very helpful in the workup of patients (Table 63. Ultimately, however, renal biopsy is often necessary to make a deinitive diagnosis. Important Causes of Nephritic Syndrome Acute Diffuse Proliferative Glomerulonephritis (Postinfectious Glomerulonephritis) his syndrome is most commonly seen in children and less often in adults. Presentation is either in a sporadic or epidemic form, 1 to 3 weeks after infection with nephritogenic strains of group A beta-hemolytic streptococcal infection (pharyngitic strains 12, 2, 1, and 25) afecting the throat or 3 to 6 weeks after a skin infection (pyoderma strains 49, 2, 42). Renal pathology is characterized by global hypercellularity of endothelial and mesangial cells in the glomeruli and an increase in the mesangial matrix. Immunoluorescence shows three patterns of immune deposits: a starry-sky pattern, which is most typical, garland pattern, and mesangial pattern. Treatment should be focused on eliminating the streptococcal infection with antibiotics and providing supportive therapy until spontaneous resolution of glomerular inlammation occurs. IgA Nephropathy or Berger Disease In 1968 Berger and Hinglais described a group of patients with episodic macrohematuria, persistent microhematuria, and moderate proteinuria. It is more common among Asian and Native American populations and rare in African Americans. Gross hematuria is often the irst presenting symptom 24 to 48 hours following a pharyngeal or gastrointestinal infection, vaccination, or strenuous exercise. Clinical presentation is characterized by an abrupt onset of cola-colored urine, puiness of face and eyelids, moderate proteinuria, and hypertension. Reduction of C3 seldom persists for >8 weeks (an important inding to diferentiate from membranoproliferative glomerulonephritis, which shows a persistent decrease in complement levels). In children, with symptomatic management, 95% recover clinically within 2 months of onset and morphologically within 3 years, although a few may progress to chronicity. However, the use of steroids remains controversial and may be more efective in IgA patients with nephrotic syndrome and minimal change disease. Treatment with ish oil is controversial; a metaanalysis suggests that patients at high risk of progression (male gender, hypertension, presence of microhematuria, presence of proteinuria, and renal insuiciency) may beneit. A combination of oral cyclophosphamide, dipyridamole, and low-dose warfarin has not demonstrated long-term beneits. Markers for a worse prognosis are persistent hypertension, proteinuria, nephrotic syndrome, persistent microhematuria, old age, and male sex (present at initial presentation). In 20% to 60% of patients, there is a prodrome of an upper respiratory tract infection that precedes the disease. Patients usually have subnephrotic proteinuria (<3 g/24 h), hematuria, a nephritic urinary sediment, and hypochromic microcytic anemia of the iron deiciency type. A chest x-ray showing abnormal bilateral hilar and basilar interstitial shadowing would point strongly to associated pulmonary hemorrhage and a diagnosis of Goodpasture syndrome.

For many years treatment hemorrhoids buy compazine with paypal, penicillamine was used in the hope of arresting the skin involvement medicine januvia order compazine 5 mg mastercard, but its high toxicity and limited eicacy have decreased its use medicine 1900s spruce cough balsam fir buy cheap compazine line. Other studies have evaluated methotrexate treatment uterine fibroids best purchase compazine, cyclosporine A symptoms yeast infection generic compazine 5 mg, and mycophenolate mofetil for severe skin disease, but the results have been inconclusive. Several trials evaluating cyclophosphamide for Idiopathic Inflammatory Myopathies: Polymyositis, Dermatomyositis, and Inclusion Body Myositis Idiopathic inlammatory myopathies such as polymyositis and dermatomyositis are rare disorders that have an increased incidence in women. In polymyositis, the involvement is restricted to the muscles and occasionally the lungs, whereas in dermatomyositis the skin can be involved as well. In more pronounced disease, diiculty swallowing and breathing can be problematic because individuals may have esophageal muscle weakness and respiratory muscle weakness. Some patients may present with muscle achiness and pain on palpation, especially during the acute phase. On physical examination, the neck lexors, upper arms, and hip lexors in individuals with polymyositis and dermatomyositis are weak. For those with inclusion body myositis, symptoms have a slower onset and more distal muscles are involved. Relux, abnormal peristalsis, and delayed gastric emptying have all been described. Laboratory Abnormalities In myositis, muscle enzymes such as the creatinine kinase and aldolase are often elevated. Serum aspartate aminotransferase and alanine aminotransferase can increase as well. Differential Diagnosis Other clinical presentations that can mimic those of idiopathic inlammatory muscle disease include thyroid disease, toxic metabolic syndromes, drug reactions, steroid myopathy, and some infectious diseases. Fixed errors of metabolism that lead to elevations of creatinine kinase and weakness, in particular after exercise, can also be diicult to distinguish from idiopathic inlammatory myopathies. Gottron papules are reddish scaly patches that appear over the knuckles of the hands and may occur over the extensor surfaces of the elbows as well. Individuals with dermatomyositis may also have a reddish-purplish rash around the eyes and on the eyelids, referred to as a "heliotropic rash. Laboratory testing is helpful because the majority of patients with inlammatory myopathy will have signiicant elevations in their muscle enzymes such as the creatinine kinase and/or aldolase levels. In addition, elevated liver function tests can be a clue that there is underlying myopathy. In dermatomyositis, pathology reveals perivascular inlammation around the muscle ibers whereas in polymyositis, inlammation within the muscle ibers is seen. Special staining and electron microscopy are necessary to make the diagnosis of inclusion body myositis. Findings in this disorder include eosinophilic and basophilic granules in the vacuoles as well as abnormal tubular ilaments of unknown signiicance. Interstitial lung disease occurs in 10% of all myositis patients and upwards of 50% of patients who have a positive anti­Jo-1 antibody. Presenting symptoms include dyspnea on exertion, a nonproductive cough, and hypoxemia. On examination, dry crackles are heard, and decreased difusion capacity is found in pulmonary function tests. In addition to the aforementioned, swallowing diiculties experienced by patients can lead to chronic aspiration and resultant pulmonary disease. Cardiac Rarely, patients will have involvement of the cardiac conduction system that can lead to either heart block or arrhythmias. Malignancy Association Both polymyositis and dermatomyositis are associated with a higher incidence of malignancies, dermatomyositis more so than polymyositis. In cases of coexisting inlammatory myopathy and malignancy, most lesions are diagnosed within 2 years of the initial diagnosis of muscle disease. Treatment he treatment of polymyositis/dermatomyositis is focused on the rapid reduction of muscle inlammation. High-dose steroids (1 mg/kg/d of prednisone equivalent) are generally given for the irst 6 weeks of therapy. Azathioprine or methotrexate can be added both to hasten disease improvement and also to facilitate the lowering of the steroid dose. In cases resistant to this approach, intravenous immunoglobulin has been used successfully. Mycophenolate mofetil, cyclosporine A, and tacrolimus have been efective in some drug-resistant cases. Monitoring response to therapy is done by physical examination and laboratory testing. Once the active phase of inlammation is controlled, physical rehabilitation to regain muscle strength is an important part of the treatment plan. It is our hope that, with better understanding of the pathophysiology of these disorders and the development of newer therapies, our treatment of these disorders will continue to improve. A 23-year-old woman presents with a history of malaise, facial rash, and achiness. Complete blood count with diferential, liver function tests, creatinine and urinalysis C. A 43-year-old woman presents with a deep vein thrombosis with no clear precipitant. Her medical history is notable for two irst trimester miscarriages and one second trimester miscarriage. She is inding it diicult to comb her hair, get out of a chair, and navigate steps. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus. Derivation and validation of the Systemic Lupus International Collaborating Clinics classiication criteria for systemic lupus erythematosus. Systemic vasculitic syndromes can present clinically in protean fashion and may be caused by a variety of mechanisms involving immune dysregulation that leads to endovascular inlammation. However, these immune mechanisms are still not well understood; therefore one must rely on clinical, descriptive parameters for classiication and treatment. Clinical syndromes that can mimic vasculitis include endocarditis, atrial myxoma, atheroembolism, and hypercoagulable states such as antiphospholipid syndrome. Other signs and symptoms, such as weight loss, night sweats, rash, mononeuritis, arthritis, and malaise without identiiable etiology, can represent clinical features of an underlying vasculitis. Upper respiratory tract involvement may lead to damage to nasal cartilage, resulting in the saddle-nose deformity. Other less common chest radiographic abnormalities include paratracheal masses, large cavitary lesions, and massive pleural efusion. Urinalysis reveals renal involvement in approximately 80% of patients at presentation. Functional renal impairment may progress rapidly if appropriate therapy is not instituted promptly. Rituximab is dosed at 375 mg/m2 weekly for 4 weeks or 1 g every 2 weeks for two doses; in both cases concomitant with high dose steroids. Repeat doses of rituximab can be given in a maintenance phase if signs of recurrence occur or on a variable basis determined by disease course. Similar, if cyclophosphamide is the inducing agent, it can be given orally up to 2 mg/kg with adjustments for renal function or intravenously 500 to 1000 mg/m2 monthly or 15 mg/kg every 3 weeks. Initial treatment with corticosteroids is generally given as prednisone, 1 mg/kg/d orally. In a critically ill patient with severe systemic involvement, pulse corticosteroid with intravenous methylprednisolone 1 g/d for 3 days is advocated, transitioning to prednisone 1 mg/kg/d orally or its intravenous equivalent. Cyclophosphamide can be administered as monthly intravenous boluses, every 3 weeks intravenous bolus, or as a daily oral dose. In severe cases, there may be a role for plasmapheresis, which may preserve renal function. In less severe cases or in step-down therapy to maintain remission, therapy with methotrexate, mycophenolate, azathioprine, and abatacept may be an option. In more severe disease, use of cyclophosphamide and other immunosuppressive agents such as azathioprine or mycophenolate may be guided using the ive-factor score. Pathology shows ibrinoid necrosis and pleomorphic cellular iniltration of lymphocytes, macrophages, and polymorphonuclear leukocytes involving the entire wall of the blood vessel. Drug-Induced Vasculitis Certain drugs and vaccines can cause vasculitis through a variety of mechanisms. In general, cases of drug-induced vasculitis can cause a self-limiting illness that resolves with discontinuation of the ofending agent or can lead to multiorgan involvement. Cryoglobulinemic Vasculitis Cryoglobulins are immunoglobulins that precipitate below 37°C. When there is no underlying etiology it is known as cryoglobulinemic vasculitis, and when associated with hepatitis C it is known as hepatitis C virus­associated cryoglobulinemic vasculitis. Regardless of the laboratory indings, if there is signiicant suspicion for the diagnosis then a temporal artery biopsy should be performed. If the patient is experiencing visual symptoms at the time of consideration of the diagnosis, high-dose corticosteroid therapy should be instituted immediately to prevent permanent visual loss; then a temporal artery biopsy should be obtained as soon as possible. If the initial biopsy is negative, the contralateral temporal artery may ofer a small additional yield diagnostically, although in some patients in whom both biopsies are negative it may be necessary to treat because the index of suspicion is high. In general, a negative biopsy evaluation (where both are done when the irst is negative) has a negative predictive value of >91%. Patients will typically present with claudication of the upper or lower extremities, especially involving the subclavian arteries, although the diagnosis should be considered in any young patient with diminished pulse and constitutional symptoms. Constitutional symptoms such as fatigue, headache, and weight loss are often noted before claudication, and hypertension can occur as well. Diagnosis should be suspected in a young patient, particularly female, with constitutional symptoms and absent or diminished pulses or bruits on examination. Treatment is high doses of corticosteroids, although some patients will not respond without addition of cytotoxic therapy. Behçet Disease Behçet disease is characterized by the presence of recurrent aphthous or genital stomatitis that can, in a subset of patients, also exhibit vasculitis of various-size vessels resulting in ocular involvement, intracranial hemorrhage, meningoencephalitis, and stroke. Although angiography may in some cases show classic indings of vasculitis, a biopsy of suspected areas is frequently necessary to make the diagnosis. Treatment includes high doses of corticosteroids and sometimes cytotoxic agents; however, there is a paucity of clinical trials to make deinitive treatment recommendation with this rare disorder. Treatment Strategies in Vasculitis Note that morbidity in vasculitides can be tied not only to end-organ efects of disease but to the treatment used to control the underlying disease. Morbidity associated with corticosteroids is well documented, including diabetes, osteoporosis, infection, poor wound healing, cataracts, hypertension, and obesity among many other side efects. In a patient with known vasculitis who presents with clinical deterioration, a source of infection should be pursued aggressively before, or concomitant with, escalation of immunosuppressive therapy. He is intubated with copious bloody secretions evident from the endotracheal tube. Which tests should be considered as part of the diagnostic evaluation in this patient A 45-year-old male with long-standing asthma is evaluated for new-onset fever, fatigue, skin rash, and worsening dyspnea. He had been using his albuterol inhaler more frequently and requiring more oral steroids and was recently started on a leukotriene antagonist. He complains of difuse abdominal pain, and his chest x-ray shows bilateral patchy iniltrates; his white blood cell count is 15,000/L with 25% eosinophils. His examination is notable for palpable purpura and weakness in the wrist lexors on his left. A 70-year-old female with a history of hypertension presents with fatigue and pain in her shoulders and hips for 1 month. Vision is normal, no scalp tenderness, but there is tenderness over the facial artery on the left. Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab. Prognostic factors of survival in patients with non infectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. When they involve the soft this sues near a joint, they can be associated with decreased range of motion of the joint and the resultant loss of function can be signiicant. Imaging and laboratory testing, when indicated, may help eliminate other diagnoses such as fracture or signiicant arthritis damage but rarely conirm a soft tissue pain syndrome. Classification of Disorders Soft tissue pain can be categorized into a few major categories. Some patients may have overlap features or more than one condition simultaneously. In this condition, the histopathology of excised soft tissue demonstrates scarring and ibrosis sometimes associated with an inlammatory iniltrate surrounding the entrapped median nerve. However, in most other disorders the indings may be minimal; for example, in some patients with recurrent shoulder pain, there may be some thinning of the tendon sheaths with sparse inlammatory cell iniltrates and occasional ibrosis. In some patients with soft tissue pain, the origin of the discomfort lies within the bursae. Subcutaneous bursae permit the movement of skin overlying the bursae, thus preventing stretching or tearing of the soft tissues. In general, bursae contain trace amounts of lubricating synovial luid, which contains a high content of hyaluronic acid with few leukocytes and some mononuclear cells. A common feature to all these conditions is that the musculoskeletal areas that are symptomatic are not the actual pain generating sites.

Purchase 5 mg compazine mastercard. What is bronchiolitis? Signs symptoms and treatment.

References

• Osterberg A, Boivie J,huomas KA. Central pain in multiple sclerosis - prevalence and clinical characteristics. Eur J Pain 2005;9:531-542.
• Wymer KM, Anderson BB, Wilkens AA, et al: Megacystis microcolon intestinal hypoperistalsis syndrome: case series and updated review of the literature with an emphasis on urologic management, J Pediatr Surg 51:1565n1573, 2016.
• Herna'ndez-Pando R, Aguilar-Leon D, Orozco H, et al. 16a-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. Journal Infect Dis 2005; 191: 299-306.
• Belghiti J, Guevara OA, Noun R, et al. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg. 2001;193:109-111.
• Finger P, Harbour JW, Karacioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol. 2002;47:1-16.
• Twine CP, Williams IM. Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms. Br J Surg 2011;98:346-353.
• Saw J, Brennan DM, Steinhubl SR, et al. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol. 2007;50:291-295.